HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Rheumatology
Cohort
H. pylori prevalence 34.3% in French Guiana; gastric adenocarcinoma found in 1.65%
One Third of Stomach Tests Show Hidden Bacteria Risk
A retrospective cohort study of 545 patients with H. pylori infection at Cayenne Hospital found a histological prevalence of 34.3%. Gastric …
A new look at stomach biopsies shows one in three patients carry a hidden bacteria that can lead to serious disease.
Frontiers
Apr 28, 2026
Pediatrics
Cohort
Retrospective study compares antibiotic regimens for H. pylori eradication in children.
Two antibiotic regimens cleared H. pylori in most children within four weeks.
This retrospective observational study evaluated two antibiotic combinations for treating Helicobacter pylori infection in children aged 4 t…
A look at two common treatments found that both regimens successfully eliminated the bacteria in most children within four weeks.
Frontiers
Apr 23, 2026
Pediatrics
Cohort
Bismuth-containing quadruple therapy associated with higher H. pylori eradication rates compared to triple therapy in children.
New Mix Clears Stomach Bugs Better in Children
This retrospective cohort study of 161 pediatric patients compared 14-day bismuth-containing quadruple therapy against triple therapy for He…
A four-drug plan works better than the usual three-drug plan for clearing stomach bacteria in kids.
Frontiers
Apr 22, 2026
Infectious Disease
Cohort
Monoclonal stool antigen test shows high accuracy for H. pylori detection in chronic atrophic gastritis patients.
A Simple Stool Test Spots a Dangerous Stomach Bug Without a Scope
This prospective primary care study evaluated 287 patients with chronic atrophic gastritis (CAG) using a monoclonal stool antigen test (SAT)…
A simple stool test spots dangerous stomach bugs in people with chronic gastritis, performing even better when the stomach is most at risk.
Frontiers
Apr 18, 2026
Infectious Disease
Meta-analysis
Meta-analysis finds vonoprazan-based therapies achieve 94% H. pylori eradication in Asian populations
The Two-Drug Combo Clearing Stomach Bacteria Where Others Are Failing
A systematic review and meta-analysis of 7,498 Asian patients with Helicobacter pylori infection compared vonoprazan-amoxicillin regimens to…
A new two-drug combo clears stomach bacteria in 94% of Asian patients, outperforming standard treatments where others are failing.
Apr 14, 2026
Gastroenterology
Cohort
Gastotypes predict Helicobacter pylori infection status in gastric mucosal samples with high accuracy.
New Stomach Map Reveals Four Hidden Types
This cohort study analyzed 566 gastric mucosal samples to identify microbial community types associated with Helicobacter pylori infection s…
New stomach map reveals four distinct bacterial neighborhoods, showing stool tests cannot tell the real story happening inside your stomach …
medRxiv
Apr 14, 2026
Infectious Disease
Meta-analysis
Meta-analysis of 19,941 participants shows 83.0% eradication rates for Helicobacter pylori antibiotic regimens.
How Well Today's Antibiotics Still Clear the Stomach Bug Behind Ulcers
This systematic review and meta-analysis evaluated antibiotic regimens for Helicobacter pylori eradication across 57 studies involving 19,94…
Current antibiotics clear the ulcer-causing stomach bug in about 83% of patients, meaning roughly 1 in 6 people still need a second round of…
Frontiers
Apr 13, 2026
Anesthesiology & Pain Medicine
Cohort
Vonoprazan-based regimens show higher H. pylori eradication rates than rabeprazole dual therapy in Chinese cohort
A New Stomach Infection Treatment Works Where Old Ones Often Fail
A retrospective cohort study of 598 H. pylori-positive outpatients in Guizhou, China, found vonoprazan-based regimens achieved eradication r…
For millions struggling with a common and stubborn stomach bug, a new treatment approach just proved it can succeed where standard care freq…
Frontiers
Apr 11, 2026
Gastroenterology
Guideline
H. pylori eradication reduces gastric cancer risk by up to 44%, per guideline review
Review finds H. pylori eradication reduces risk of stomach cancer and ulcers
A narrative review of global evidence indicates H. pylori eradication reduces the risk of peptic ulcer recurrence, dyspepsia, and gastric ca…
Treating a common stomach bacteria infection can lower future cancer risk by up to 44% and prevent recurring ulcers.
Frontiers
Apr 3, 2026
Gastroenterology
Meta-analysis
Genetic study links H. pylori susceptibility to HLA and innate immunity genes, suggests causal disease relationships
Large genetic study finds links between H. pylori infection susceptibility and autoimmune diseases
A meta-analysis of up to 140,863 Japanese and European individuals identified significant genetic associations for H. pylori infection susce…
A large genetic study reveals specific immune system genes linked to H. pylori infection and autoimmune diseases like type 1 diabetes and Ha…
medRxiv
Apr 2, 2026